Exact Sciences
EXAS
#1542
Rank
S$14.89 B
Marketcap
$80.49
Share price
5.86%
Change (1 day)
-17.36%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$4.79 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are S$4.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$4.39 B2.92%
2022-12-31S$4.26 B-4.25%
2021-12-31S$4.45 B25.28%
2020-12-31S$3.55 B116.73%
2019-12-31S$1.64 B42.54%
2018-12-31S$1.15 B1002.02%
2017-12-31S$0.10 B72.99%
2016-12-31S$60.41 M14.9%
2015-12-31S$52.58 M66.93%
2014-12-31S$31.5 M119.81%
2013-12-31S$14.33 M-13.35%
2012-12-31S$16.53 M-5.11%
2011-12-31S$17.42 M-19.27%
2010-12-31S$21.59 M-21.84%
2009-12-31S$27.62 M131.85%
2008-12-31S$11.91 M-0.33%
2007-12-31S$11.95 M-12.51%
2006-12-31S$13.66 M-37.95%
2005-12-31S$22.01 M-25.55%
2004-12-31S$29.57 M-22.47%
2003-12-31S$38.14 M87.32%
2002-12-31S$20.36 M166.18%
2001-12-31S$7.65 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$0.47 B-90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
S$29.55 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$82.44 B 1,619.69%๐Ÿ‡ซ๐Ÿ‡ท France